Ultimate magazine theme for WordPress.

- реклама -

AstraZeneca admits its vaccine causes clotting #covishield #astrazeneca #coronavaccine #latestnews

0

AstraZeneca Admits Rare Blood Clot Risk with Covishield Vaccine: Should We Be Worried?

AstraZeneca has recently acknowledged that its COVID-19 vaccine, Covishield, can cause blood clots in extremely rare cases. However, experts emphasize that the risk of this side effect is minimal and short-lived, typically occurring within a few weeks of vaccination. Moreover, most individuals who received the vaccine have already surpassed this timeframe. Additionally, a study published in Lancet Global Health found a mere 0.2 cases of blood clots per 10 lakh doses administered in Asian countries. While it’s crucial to be aware of potential vaccine side effects, it’s essential to weigh these risks against the overwhelming benefits of vaccination in protecting against COVID-19.

Key Points:

AstraZeneca acknowledges rare blood clot risk associated with Covishield vaccine.
Risk is minimal and short-lived, typically occurring within a few weeks of vaccination.
Most individuals have already surpassed this timeframe.
Study shows a low incidence of blood clots in Asian countries.
Weigh vaccine risks against the benefits of protection against COVID-19.
#covishield #covishieldvaccine #astrazeneca #astrazenecavaccine #vaccinesafety #BloodClots #covid19 #covid19news #vaccine #breakingnews #latestnews #currentaffairs #upsc

Оставьте ответ

Ваш электронный адрес не будет опубликован.